What is cjd disease

Overview

Creutzfeldt-Jakob disease (CJD) is a rare but fatal brain disorder that affects approximately one to two people per million worldwide. The disease is caused by prion proteins—misfolded versions of a normal brain protein—that accumulate in the brain tissue, causing progressive neurological deterioration. CJD is one of a group of diseases called transmissible spongiform encephalopathies (TSEs) because the brain tissue becomes filled with holes, giving it a sponge-like appearance under a microscope.

Types of CJD

Sporadic CJD: The most common form, accounting for about 85% of cases. It appears to occur randomly without known cause. Familial (Hereditary) CJD: Caused by inherited genetic mutations in the prion protein gene, accounting for about 10% of cases. Acquired CJD: Includes variant CJD (vCJD) linked to consuming beef infected with mad cow disease, and iatrogenic CJD from contaminated medical procedures. Variant CJD became prominent in the 1990s in the United Kingdom.

Symptoms and Progression

CJD symptoms typically begin with memory problems, behavioral changes, and difficulty concentrating. As the disease progresses, patients develop increasingly severe symptoms including involuntary movements, rigidity, loss of consciousness, and eventual complete loss of brain function. The rapid progression distinguishes CJD from other dementias. Most patients become immobilized and unable to communicate as the disease advances. Progression is relentless, typically resulting in death within months, though some cases progress more slowly over a year or more.

Diagnosis and Treatment

Diagnosis involves brain MRI showing characteristic patterns, cerebrospinal fluid tests, and EEG recordings. Definitive diagnosis currently requires brain biopsy, though this is rarely performed. There is no cure for CJD. Treatment is symptomatic, focusing on comfort care and management of symptoms like pain and seizures. Research into potential treatments is ongoing, but no disease-modifying therapies have proven effective in clinical trials. Early palliative care and support for patients and families are important components of management.